144 related articles for article (PubMed ID: 424842)
1. Oxybutynin chloride in the management of idiopathic detrusor instability.
Paulson DF
South Med J; 1979 Mar; 72(3):374-5. PubMed ID: 424842
[No Abstract] [Full Text] [Related]
2. Oxybutynin hydrochloride in the management of detrusor instability.
Primus G; Pummer K
Int Urol Nephrol; 1990; 22(3):243-8. PubMed ID: 2210980
[TBL] [Abstract][Full Text] [Related]
3. [Instability of the detrusor muscle. Treatment with oxybutynin chloride (ditropan)].
Perales Cabanas L; Tallada Buñuel M; Romero Maroto J; Escribano Patiño G
Actas Urol Esp; 1986; 10(6):481-6. PubMed ID: 3825651
[No Abstract] [Full Text] [Related]
4. Ambulant monitoring to assess the efficacy of oxybutynin chloride in patients with mixed incontinence.
van Waalwijk van Doorn ES; Zwiers W
Eur Urol; 1990; 18(1):49-51. PubMed ID: 2401307
[TBL] [Abstract][Full Text] [Related]
5. The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study.
Tapp AJ; Cardozo LD; Versi E; Cooper D
Br J Obstet Gynaecol; 1990 Jun; 97(6):521-6. PubMed ID: 2198921
[TBL] [Abstract][Full Text] [Related]
6. Intravesical instillation of oxybutynin hydrochloride for detrusor hyper-reflexia.
O'Flynn KJ; Thomas DG
Br J Urol; 1993 Nov; 72(5 Pt 1):566-70. PubMed ID: 10071538
[TBL] [Abstract][Full Text] [Related]
7. The treatment of detrusor instability in postmenopausal women with oxybutynin chloride: a double blind placebo controlled study.
Moore KH; Goldstein M; Hay D
Br J Obstet Gynaecol; 1990 Nov; 97(11):1063-4. PubMed ID: 2082973
[No Abstract] [Full Text] [Related]
8. Terodiline and oxybutynin in detrusor instability.
Drug Ther Bull; 1988 May; 26(10):37-8. PubMed ID: 3383752
[No Abstract] [Full Text] [Related]
9. Oxybutynin chloride in the treatment of female idiopathic bladder instability. Results from double blind treatment.
Riva D; Casolati E
Clin Exp Obstet Gynecol; 1984; 11(1-2):37-42. PubMed ID: 6370504
[TBL] [Abstract][Full Text] [Related]
10. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.
Yarker YE; Goa KL; Fitton A
Drugs Aging; 1995 Mar; 6(3):243-62. PubMed ID: 7620236
[TBL] [Abstract][Full Text] [Related]
11. Persistence of detrusor hyperreflexia in a continent, institutionalized elderly patient with Parkinson's disease.
Starer P; Libow LS
N Y State J Med; 1991 Apr; 91(4):166-7. PubMed ID: 2047037
[No Abstract] [Full Text] [Related]
12. Intravesical oxybutynin chloride: experience with 42 patients.
Weese DL; Roskamp DA; Leach GE; Zimmern PE
Urology; 1993 Jun; 41(6):527-30. PubMed ID: 8516987
[TBL] [Abstract][Full Text] [Related]
13. [Topical treatment with oxybutynin chloride in neurogenic incontinence].
López Pereira P; Martínez MJ; Muguerza R; Jaureguizar E
Cir Pediatr; 1993 Jan; 6(1):29-31. PubMed ID: 8499234
[TBL] [Abstract][Full Text] [Related]
14. Oxybutynin and incontinence during grand mal seizures.
Harari D; Malone-Lee JG
Br J Urol; 1991 Dec; 68(6):658. PubMed ID: 1773301
[No Abstract] [Full Text] [Related]
15. Urinary incontinence in the elderly.
Snustad DG; Rosenthal JT
Am Fam Physician; 1985 Nov; 32(5):182-96. PubMed ID: 4061247
[No Abstract] [Full Text] [Related]
16. Oxybutynin chloride for geriatric urinary dysfunction: a double-blind placebo-controlled study.
Zorzitto ML; Holliday PJ; Jewett MA; Herschorn S; Fernie GR
Age Ageing; 1989 May; 18(3):195-200. PubMed ID: 2675580
[TBL] [Abstract][Full Text] [Related]
17. The use of intravesical oxybutynin chloride in children with neurogenic bladder.
Greenfield SP; Fera M
J Urol; 1991 Aug; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294
[TBL] [Abstract][Full Text] [Related]
18. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
Goldenberg MM
Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
[TBL] [Abstract][Full Text] [Related]
19. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U
World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
[TBL] [Abstract][Full Text] [Related]
20. Tethered cord syndrome in an adult. Pharmacological treatment of the urological symptomatology by oxybutynin.
De Angelis M; Martina G; Caverni L; Coglitore A; Libanori GP; Giannotti P
Acta Urol Belg; 1986; 54(1):99-105. PubMed ID: 3962800
[No Abstract] [Full Text] [Related]
[Next] [New Search]
